Ingevity Corp
NYSE:NGVT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Ingevity Corp
Total Equity
Ingevity Corp
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ingevity Corp
NYSE:NGVT
|
Total Equity
$568.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Sherwin-Williams Co
NYSE:SHW
|
Total Equity
$3.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
8%
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Total Equity
$14.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
Dupont De Nemours Inc
NYSE:DD
|
Total Equity
$23.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Ecolab Inc
NYSE:ECL
|
Total Equity
$8.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
PPG Industries Inc
NYSE:PPG
|
Total Equity
$7.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
3%
|
See Also
What is Ingevity Corp's Total Equity?
Total Equity
568.2m
USD
Based on the financial report for Mar 31, 2024, Ingevity Corp's Total Equity amounts to 568.2m USD.
What is Ingevity Corp's Total Equity growth rate?
Total Equity CAGR 5Y
10%
Over the last year, the Total Equity growth was -22%. The average annual Total Equity growth rates for Ingevity Corp have been -5% over the past three years , 10% over the past five years .